Entrada Therapeutics, Inc., is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle, therapeutic candidates...
61 insider purchases on record · latest filing 2026-05-21.
Insiders have also filed 205 sale transactions at TRDA.